Dr. Voineskos is Director of the Slaight Family Centre for Youth in Transition, and is Head of the Kimel Family Translational Imaging-Genetics Laboratory in the Campbell Family Mental Health Research Institute at CAMH. He is a Canada Research Chair in Neuroimaging of Schizophrenia, and Associate Professor of Psychiatry at the University of Toronto.

Dr. Voineskos’s work combines multi-modal neuroimaging and genetics approaches to map gene effects on brain circuitry with a view to discovering vulnerability pathways for severe mental illness using a lifespan approach. He also holds a special interest in leading early identification and intervention for young people with emerging mental illness. He received his medical degree and his PhD from the University of Toronto.

A related area of Dr. Voineskos’s work includes using structural and functional neuroimaging in medication-based, brain stimulation and behavioral treatment studies in schizophrenia and related disorders. This approach identifies the effects of existing and new treatments on brain structure and function, and aims to use neuroimaging to predict treatment response. He is currently leading several multi-site neuroimaging studies in North America. He currently holds operating funding as Principal Investigator from the NIMH (R01MH099167 and R01MH102324), CIHR, CFI, Ontario MRI, OMHF, and as a NARSAD Independent Investigator.

He is one of the three Greeks featured to the prestigious “Top 40 Under 40” list of Canada’s top young movers and shakers. “Top 40 Under 40” is a dynamic awards program that identifies outstanding young achievers in Canadian business, visionaries and innovators changing the way things are done.